NextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD

BOSTON–(BUSINESS WIRE)–NextRNA Therapeutics, a biotechnology company unlocking the potential of long non-coding RNAs (lncRNAs) to develop transformative medicines for multiple diseases with an initial focus on oncology and neurology, today announced the appointment of Lori Friedman, PhD, to its Board of Directors. Dr. Friedman is currently Chief Scientific Officer of…
Click here to view original post